Please ensure Javascript is enabled for purposes of website accessibility

Coronavirus Testing Hopes Lift Shares of BJ's, Dave & Buster's, and Bloomin' Brands

By Jon Quast – Updated Aug 28, 2020 at 5:14PM

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

These restaurants are still hurting from the pandemic, but the rapid tests could help things return to normal.

What happened

On Aug. 26, the Food and Drug Administration authorized a new coronavirus test from Abbott Laboratories that is quicker and cheaper than anything else so far. And investors believe that's good news for beaten-down restaurant stocks like BJ's Restaurants (BJRI -0.46%), Dave & Buster's Entertainment (PLAY 1.20%) and Bloomin' Brands (BLMN 1.93%). Each stock is still down in 2020, but with each new encouraging development in the ongoing COVID-19 saga, investors purchase shares in anticipation of a turnaround.

Today, BJ's Restaurants stock was up 14%, Dave & Buster's shares were up 16%, and Bloomin' Brands was up 9%. It was a continuation of the momentum from the previous day, right after the rapid tests were announced.

PLAY Chart

PLAY data by YCharts.

So what

All casual-dining restaurants have been challenged in 2020. The pandemic forced dining rooms to limit seating or close altogether, and not many chains were equally equipped to facilitate to-go operations. But these three restaurant companies are particularly challenged.

Bloomin' Brands has a large portfolio of over 1,450 restaurants divided among four brands. Therefore, each brand needs custom adjustments to weather the storm. Dave & Buster's serves food, but it's really the in-store gaming and hanging-out experience that sets it apart -- not very adaptable in the crisis. For its part, BJ's Restaurants has a large percentage of locations (30%) in California, a state with strict dine-in regulations.

While Bloomin' Brands and BJ's Restaurants have grown their respective to-go operations, they haven't come close to replacing the sales they've lost. Dave & Buster's has only experimented with curbside delivery in a couple of stores so far. In short, sales are down for all three because of COVID-19, and they likely won't recover until dining rooms can reopen normally.

That's where the rapid coronavirus tests from Abbott come in. The federal government reportedly ordered 150 million tests to help get the pandemic under control. And the company believes it can ship 50 million a week by October. These could, in theory, be used to safely reopen dining rooms, giving these restaurant stocks a fighting chance to return to normal. And with each stock still down from 52-week highs, investors are betting they'll return to highs once restaurant activity is back to normal.

Stacks of wood blocks in a row are sequentially taller and each is topped with an arrow that points up.

Image source: Getty Images.

Now what

Investors should tap the brakes on their optimism for two reasons. First, we have no idea how feasible it will be to test people before dining in a restaurant. Will patrons want to be swabbed and wait in line for the 15 minutes it takes to get results? We don't know. Will local legislators even believe the tests are good enough to allow full dine-in seating? We don't know. 

Second, these companies have been through the ringer. When athletes break a leg, they're not the same players they were as soon as the cast is removed; rehab takes time. Likewise, BJ's Restaurants, Dave & Buster's, and Bloomin' Brands have taken on debt to varying degrees. And they've received rent relief from landlords, but that'll have to be repaid down the line. In short, even when restaurants are operating at normal capacity, the businesses will still need time to get back to where they were pre-pandemic. 

Does that mean they're bad investments? Not necessarily. These three stocks will have to be evaluated on an individual basis to judge the long-term prospects. But consider this: A full 85% of independent restaurants are still at risk of closing permanently in 2020, according to the Independent Restaurant Coalition. Even some chain restaurants like Dunkin' Brands Group and Yum! Brands' Pizza Hut are permanently closing locations. 

This most likely means we will have fewer restaurants at the start of 2021 than we had at the beginning of 2020. But this sober reality actually creates an opportunity for restaurants that make it through to the other side. Assuming demand stays the same, there will be fewer options. Therefore, the remaining restaurants will get that business, boosting sales to higher levels.

Personally, I believe consumers are adopting the convenience of third-party delivery, which will benefit quick-service and fast-casual chains more than these casual-dining restaurant stocks. But even if I'm wrong, investors need to keep in mind that the new coronavirus tests aren't immediate fixes for the problems at BJ's Restaurants, Dave & Buster's, and Bloomin' Brands. As always when investing in stocks, you have to take a long-term view, since it may take some time for your investing thesis to prove itself. 

Jon Quast has no position in any of the stocks mentioned. The Motley Fool recommends Dave & Busters Entertainment and Dunkin' Brands Group. The Motley Fool has a disclosure policy.

Invest Smarter with The Motley Fool

Join Over 1 Million Premium Members Receiving…

  • New Stock Picks Each Month
  • Detailed Analysis of Companies
  • Model Portfolios
  • Live Streaming During Market Hours
  • And Much More
Get Started Now

Stocks Mentioned

BJ's Restaurants, Inc. Stock Quote
BJ's Restaurants, Inc.
$23.68 (-0.46%) $0.11
Bloomin' Brands Stock Quote
Bloomin' Brands
$18.53 (1.93%) $0.35
Dave & Buster's Entertainment, Inc. Stock Quote
Dave & Buster's Entertainment, Inc.
$31.16 (1.20%) $0.37
Yum! Brands, Inc. Stock Quote
Yum! Brands, Inc.
$107.77 (-1.27%) $-1.39
Dunkin' Brands Group, Inc. Stock Quote
Dunkin' Brands Group, Inc.
Abbott Laboratories Stock Quote
Abbott Laboratories
$98.33 (-1.51%) $-1.51

*Average returns of all recommendations since inception. Cost basis and return based on previous market day close.

Related Articles

Motley Fool Returns

Motley Fool Stock Advisor

Market-beating stocks from our award-winning analyst team.

Stock Advisor Returns
S&P 500 Returns

Calculated by average return of all stock recommendations since inception of the Stock Advisor service in February of 2002. Returns as of 09/27/2022.

Discounted offers are only available to new members. Stock Advisor list price is $199 per year.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.